Patent · US Active

Alpha-hemolysin variants

US10752948B2 · kind B2 · utility

2Cited by

0References

25Claims

0Family size

Assignee

Roche Sequencing Solutions, Inc. · US

Inventors

Timothy Craig · Campbell, US
Cynthia Cech · Newcastle, US
Michael Dorwart · Mountain View, US
Liv JENSEN · Palo Alto, US
Marshall Porter · Santa Clara, US
Christos TZITZILONIS · Redwood City, US
Alexander Hyun-min YANG · Mountain View, US

Key dates

Filing date	Jan 3, 2019
Grant date	Aug 25, 2020
Priority date	—
Expiry date	Jan 3, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N9/1241
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.